Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Lyell Immunopharma
(LYEL) Q2 2026
Earnings
LYEL
May 6
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.6
-2.77
-1.93
-1.1
Details
Expected EPS
-1.311667
Actual EPS
-1.1
Surprise EPS
0.21
Surprise Percent
+16.14%
Description
Lyell Immunopharma (LYEL) has reported earnings of -1.1 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login